Identification of a 16-MTGs Prognostic Signature in Diffuse Large B-Cell Lymphoma

Figure 5

The GO and KEGG enrichment analysis for survival-related MTGs in DLBCL patients. GO pathways (a) and KEGG pathways (b).

(a)

(b)